about
Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cellsCOX inhibitors modulate bFGF-induced cell survival in MCF-7 breast cancer cellsEpigenetic reprogramming of HOXC10 in endocrine-resistant breast cancerS100β as a serum marker in endocrine resistant breast cancer.NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.Cytosolic phospholipase A2-α expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours.Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.The LIM domain protein LPP is a coactivator for the ETS domain transcription factor PEA3.The function of steroid receptor coactivator-1 in normal tissues and cancerProsaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expressionGlobal characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.Lapatinib: a competitor or companion to trastuzumab?Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells.Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1.HOXC11-SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinibThe role of oestrogen receptor {alpha} in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2.Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence.Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer.Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors.Growth factor-dependent regulation of survivin by c-myc in human breast cancer.Coregulatory protein-orphan nuclear receptor interactions in the human adrenal cortex.Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.Regional renal blood flow in normal and disease states.Modulation of steroidogenic enzymes by orphan nuclear transcriptional regulation may control diverse production of cortisol and androgens in the human adrenal.Methods of renal blood flow measurement.RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.An autoradiographic study of regional blood flow distribution in the rat kidney during ureteric obstruction--the role of vasoactive compounds.Cytoprotective effects of nitrates in a cellular model of hydronephrosis.Differential production of adrenal steroids by purified cells of the human adrenal cortex is relative rather than absolute.Endothelin in unilateral ureteral obstruction: vascular and cellular effects.Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients.RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer.Superoxide radical and xanthine oxidoreductase activity in the human heart during cardiac operations.Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected].Patient-Derived Xenografts of Breast Cancer.
P50
Q21090900-4F54D7ED-81A2-4385-8A09-1969600524F7Q28167501-7080D73A-6C03-4379-A62A-20B757CC1384Q30408963-94AF1B0D-9142-4A40-A803-9F23D4D46D6CQ33556608-C4994FB6-AF81-48F0-9862-6E0639B849B6Q33852340-90407EF3-A2F9-4F15-BDDD-EC030D0961E6Q34543740-42209CD2-39F2-4888-A876-C9F4B39EF982Q34589464-E5C0C75D-AFC5-426C-AEEA-51E3829E3276Q34718092-48388AA4-665D-4BA9-ABC2-CF66C1F01669Q35828548-926B26F9-39F6-4A50-A200-401CB482B4CAQ36030567-8D053236-70B7-4723-8558-5A50F752EA86Q36898979-F796069A-D87C-4BF7-B1D4-A82555F523E9Q36926842-7A7B7220-8F97-49BA-87FD-FFC1D05F0588Q37533025-63182041-440E-480E-84FC-6DA5CC09D35BQ37595970-71B4188D-9F66-461B-BC78-61D37913ABBAQ38303697-96115361-1600-42CC-BF97-E74718694587Q38846502-D84DA0B0-6FFE-4C82-BF83-DD565D9EAFACQ39321827-0E0EB7F6-D406-4026-80C8-661E2B9A80DCQ39355345-B74DBBBF-3F3D-448B-B083-5C39B90A56C4Q39438647-4D3516A0-BD90-4A77-A7AA-E89012AB06C0Q39528363-B4458251-FB34-43C5-BE52-1884D74BB426Q39759666-82CE4138-7675-432A-8A3A-387E129FF227Q39874727-2A9C4E48-14A0-42BD-8929-E3E362920696Q40039742-36B06A77-D87C-4416-8B77-55FBA0B50271Q40111774-4EF4AFBE-6DAF-4C7B-9777-81AEBF74BB14Q40196190-59207F20-0106-4467-817F-CB0F8A07C9A0Q40400581-0119ED4E-83F3-4872-88D2-02159891CE49Q40443028-AC4F5781-1145-485B-82CC-986C9EB91BDFQ40448974-5E511949-A28D-43C7-A67C-8E6E3E2620D8Q40558875-A7BD7BA0-8496-40B8-A490-FD32CFE7C382Q41137763-250F2201-248C-40F7-BCC0-977A7D908EDEQ42396417-FC1E164D-8281-4AD6-AD6F-A7B3CEFBEC65Q43697941-1FE9E9DE-8229-4E1A-BC62-2DCB5D2AE37DQ44039605-D23B729C-710D-4C6F-8AAC-FE9E53648E00Q44282380-C84F2312-76CA-4F00-9105-6A86648029B3Q44289005-005CBB9D-A878-48C2-A681-C4045C17FF90Q44335729-2DD28B55-E9CE-43B0-89DD-82573056BE2AQ45938307-CDD6A49A-DA35-406F-B699-D364CAF067C7Q50756984-74F16A49-85F5-43A0-BB01-22F0B406FF00Q51915506-5A2C91B0-E01C-49BE-A656-58BA34D273F1Q53194722-81E77E17-56E6-4B9C-BB56-52AFC3455074
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Leonie S. Young
@ast
Leonie S. Young
@en
Leonie S. Young
@es
Leonie S. Young
@nl
Leonie S. Young
@sl
type
label
Leonie S. Young
@ast
Leonie S. Young
@en
Leonie S. Young
@es
Leonie S. Young
@nl
Leonie S. Young
@sl
prefLabel
Leonie S. Young
@ast
Leonie S. Young
@en
Leonie S. Young
@es
Leonie S. Young
@nl
Leonie S. Young
@sl
P106
P1153
7403665081
P21
P31
P496
0000-0002-4904-0367